Our study is out! TIMP2, prev tied to blood-borne revitalization of aged brain, regulates hippocampal plasticity via extracell. matrix. Great teamwork f/ 1st-auth @AnaOF, +@Brittany_Hemmer, @Philippi_Sarah, Alex Perales, + more!
https://t.co/RQwUfUoyA3
https://t.co/et3mQoIxPg
Excited to share a new preprint out from the lab (https://t.co/RYFJZh3gA1) by 1st-author @brittany_hemmer , a newly minted PhD from the lab! A brief thread on what we found (1/n):
🌟Amazing full day of great discussions, 1-year progress updates & future planning as our @Eueic pathfinder #RESYNC consortium gathered in Turin. Exciting innovations ahead as we push the boundaries of chemical reprogramming!
#HorizonEurope
Read more: https://t.co/2dMjohpNhn
Join us!
Are you passionate about the brain, and want to know how neuronal circuits influence behavior?
Do you want to pursue a PhD testing the potential of modulating serotonin circuits to revert emotional/ cognitive dysfunction in neuropsychiatric disorders? Then let’s talk! https://t.co/dEKL9qSM74
📢 The Pereira Lab is hiring 2 researchers with an MSc to join the Cintech project!
➡️ Join us to advance our projects at the interface of #CellReprogramming and #Cancer#Immunotherapy
📥 Apply here until 20th of November: https://t.co/VY1Wlqplp6
Just wrapped up an incredible 3-day course on Leadership by @LifeSciLearn !Grateful for the insights, hands-on learning and the chance to connect with amazing people #Leadership#EMBOLabLead
1/23 We are excited to announce that our most recent study “In vivo dendritic cell reprogramming for cancer immunotherapy” was published in @ScienceMagazine.
https://t.co/yPDqKmpGnn
Here is a summary of what we discovered!
We are excited to announce we were awarded our third ERC grant! The ERC Proof of Concept grant #DART stands for “Driving Tumor Antigen Presentation by RNA-mediated Transdifferentiation.” #ERCPoC
📢 Want to become an expert in next-gen cell & gene therapy? Join us @lunduniversity to work on in-vivo dendritic cell reprogramming based #immunotherapy. We offer a 4y contract & integration in National #ATMP Research school. Apply/ask questions by 31/07: https://t.co/GiIJLCujh5
🔬 Join our team in the fight against #cancer!
We're looking for a motivated individual to pioneer cellular #reprogramming technology for identifying potent #neoantigens, advancing the frontier of #immunotherapy. Find more information and apply here: https://t.co/e3SwIT2K9H
Join our team! we are recruiting an administrative assistant to support our projects.
🔹 Remote work possible 🔹 Support daily admin operations 🔹 strong organizational skills required
Apply by April 30, 2024 by following the link:
https://t.co/AW8EU9pgKA
#Admin#RemoteJobs
We have a position opened for a fellowship for a MSc researcher interested in applying to a PhD program to work in our team on Alzheimer's disease pathogenesis.
DM if you're interested!
https://t.co/zkqCalpLWB
It was so much fun to put together the @EUeic pathfinder #RESYNC Kick-off and meet all partners and collaborators!
Looking forward for an amazing collaborative effort to change #cancer#immunotherapy 🔬
Thrilled to announce the Kick-off of our @EUeic pathfinder #RESYNC project in Lund! We are excited to begin the collaborative effort with @ASTRAZENECAUK to turn cancer cells into immune cells with chemical reprogramming. A big thanks to all consortium partners and collaborators!
Passionate about scientific writing?📝
Join the @CellReproLab as a Science Writer! Explore your love for research by supporting grant proposals and applications.
Your next chapter in scientific writing awaits!
(More info and link to apply in thread)
#ScienceWriter#JobOpening
🌟In 2024 we celebrate scientific freedom! We are proud to launch the Ihor Lemischka scholarship for scientific freedom, a 2-year postdoctoral scholarship with the freedom to explore your ideas and satisfy your curiosity about cell identity and the reprogramming of cell fate.
Investigadores do ICVS vencem o prémio Maria de Sousa 2023
@ndinisalves e @SaraCalafate , investigadores dos ICVS da @Med_UMinho, são distinguidos esta quinta-feira, dia 16 de novembro, com o prémio Maria de Sousa. Parabéns! Mais informação em: https://t.co/FZre92YOvG
A new study by Dr. @JM_Castell could pave the way for a better understanding of how TIMP2 could be targeted in age-related disorders like #AlzheimerDisease to help restore affected molecular processes in the brain. Learn more: https://t.co/pF6S1ydKO0
@SinaiBrain@MSHSNeurology